TABLE 4.
Time pointa | No. of evaluable patients | No (%) of patients with GM antigen | Days between GM antigen detection and time point median (range) |
---|---|---|---|
First day of fever | 7 | 1 (14.3) | 4 (4) |
First day of clinical signsb | 7 | 3 (42.8) | 9 (4-15) |
Pulmonary HRCT scan | 7 | 6 (85.7) | 7.2 (1-15) |
Initation of antifungal therapy | 7 | 4 (57.1) | 12.5 (1-23) |
At or before time point.
Cough and/or dyspnea and/or hemoptysis and/or thoracic pain.